SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Phase III Study Data on Movetis' Resolor(R) (prucalopride) for Patients With Chronic Constipation Published in Gut and Alimentary Pharmacology and Therapeutics